Olivia Manser | Director, Investor Relations |
Christian Itin | Chief Executive Officer |
Lucinda Crabtree | Chief Financial Officer |
Matt Phipps | William Blair |
Nick Abbott | Wells Fargo |
Mara Goldstein | Mizuho |
Gil Blum | Needham |
Simon Baker | Redburn |
Ladies and gentlemen, thank you for standing by and welcome to the Autolus Therapeutics First Quarter 2022 Financial Results Conference Call. [Operator Instructions] I would now like to hand the conference over to your speaker today, Olivia Manser, Director of Investor Relations. Please go ahead, ma’am.
Thank you and good morning or good afternoon everyone and thank you for joining us to take part in today’s call on the operational highlights and financial results for the first quarter of 2022. I am Olivia Manser, Director of Investor Relations.